Cancer detection using whole-genome sequencing of cell free DNA

Oncotarget

Volumn 4, Issue 8, 2013, Pages 1119-1120

  Leary, Rebecca J ^a,b   Sausen, Mark ^a,c   Diaz Jr , Luis A ^a   Velculescu, Victor E ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

^c Personal Genome Diagnostics   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CA 19-9 ANTIGEN; CARCINOEMBRYONIC ANTIGEN; DNA; EPIDERMAL GROWTH FACTOR RECEPTOR 2; PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

BREAST CANCER; CANCER DIAGNOSIS; CANCER PATIENT; CANCER RECURRENCE; CHROMOSOMAL INSTABILITY; CHROMOSOME ABERRATION; COLORECTAL CANCER; COPY NUMBER VARIATION; DNA DETERMINATION; DNA SEQUENCE; EDITORIAL; GENE MUTATION; HUMAN; ONCOGENE; OVARY CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; SINGLE NUCLEOTIDE POLYMORPHISM;

DNA, NEOPLASM; EARLY DETECTION OF CANCER; GENOME, HUMAN; HUMANS; NEOPLASMS; SEQUENCE ANALYSIS, DNA; TUMOR MARKERS, BIOLOGICAL;

EID: 84884299479     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.1183     Document Type: Editorial

References (7)

1. Leary RJ et al. Sci. Transl. Med. 2012; 4: 162ra154.
2. Nik-Zainal S, et al. Cell. 2012; 149: 994-1007.
3. Leary RJ, et al. Proc. Natl. Acad. Sci. U.S.A. 2008; 105:16224-16229.
4. Leary RJ, et al. Sci. Transl. Med. 2010; 2: 20ra14.
5. McBride DJ, et al. Genes Chromosomes Cancer. 2010; 49:1062-1069.
6. Beck J, et al. Mol Cancer Res. 2010; 8:335-42.
7. Chan KC, et al. Clin Chem. 2013; 59:211-24.